iSERA Lifesciences gave notice of a board meeting on November 4, 2026 to consider standalone unaudited results for the quarter and half year ended September 30, 2026. The filing also notes the trading window closure from October 1, 2026.
iSERA Lifesciences Ltd scheduled a board meeting for August 7, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.
iSERA Lifesciences Limited has deferred its Board Meeting scheduled for April 20, 2026. The meeting was intended to consider a preferential issue of equity shares on a private placement basis. The deferment is due to additional time required for procedural and documentation formalities related to the proposed issuance.